Quantum Genomics Société Anonyme announced that it will receive 15 million in an equity round of funding on April 26, 2022. The company has received subscriptions for 12 million from institutional investors including Otium Capital for minimum of 10 million at a maximum price of 2.80 per share and Vatel Capital SAS for 2 million to 2.5 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1292 EUR | +1.89% | +9.86% | +21.89% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.89% | 4.81M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- ALQGC Stock
- News Quantum Genomics
- Quantum Genomics Société Anonyme announced that it expects to receive €15 million in funding from Otium Capital, Vatel Capital SAS